NCT05761171 2026-03-31A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaChildren's Oncology GroupPhase 2 Active not recruiting78 enrolled
NCT07498465 2026-03-27A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute LeukemiaChildren's Oncology GroupPhase 1 Not yet recruiting29 enrolled